LINKED Intervention for HIV Prevention in Drug Addiction
What You Need to Know Before You Apply
What is the purpose of this trial?
This trial tests the LINKED social network intervention, which aims to help people who inject drugs start using PrEP (a medicine that helps prevent HIV) and MOUD (treatment for opioid addiction). Participants will join one of two groups: the LINKED intervention group, which includes a peer-led workshop, or a control group that receives general attention. The trial seeks participants in the Los Angeles area who have injected drugs in the past three months, are not currently using PrEP or MOUD, and have tested negative for HIV. As an unphased trial, this study offers a unique opportunity to contribute to innovative research that could improve health outcomes for people who inject drugs.
Will I have to stop taking my current medications?
The trial does not specify if you need to stop taking your current medications, but you cannot be on PrEP or MOUD to participate.
What prior data suggests that the LINKED intervention is safe for people who inject drugs?
Research has shown that programs like LINKED yield promising results in reducing risky behaviors among people who inject drugs. One study found that similar programs significantly reduced behaviors that increase the risk of HIV, largely due to the involvement of peer health advocates. This suggests that LINKED could be well-received and effective, as it employs a peer-driven approach to promote safer practices.
Additionally, oral PrEP (pre-exposure prophylaxis), which LINKED aims to increase the use of, has reduced HIV cases by 49% among people who inject drugs. This indicates that the intervention related to PrEP might be safe and effective.
Overall, LINKED focuses on peer support and behavior change. Studies suggest that these types of programs can safely and effectively encourage healthier behaviors in high-risk groups.12345Why are researchers excited about this trial?
Researchers are excited about the LINKED Intervention for HIV prevention in drug addiction because it offers a novel approach by using a peer change agent model. Unlike standard treatments that might rely on medication or more traditional counseling, LINKED involves a 3-hour workshop where participants engage in interactive learning and practice sessions. This method focuses on peer support and behavioral change, which could enhance engagement and effectiveness in preventing HIV among those struggling with drug addiction. By leveraging the influence of peers, the intervention aims to create a supportive community that facilitates positive change and adherence to prevention strategies.
What evidence suggests that the LINKED intervention is effective for HIV prevention in drug addiction?
Research has shown that certain programs help people who inject drugs reduce risky drug use and sexual behaviors. These programs lower the risk of HIV by encouraging healthier choices and actions. One review found that these programs lead to safer sexual practices and less drug use. In this trial, participants in the LINKED arm will receive a peer change agent intervention designed to promote healthier behaviors. Another study found that using both medication for opioid addiction and HIV treatment helps prevent and manage HIV. Overall, these programs effectively reduce HIV risk and promote healthier behaviors in this group.12567
Who Is on the Research Team?
Suzan Walters, PhD
Principal Investigator
NYU Langone Health
Are You a Good Fit for This Trial?
This trial is for people who inject drugs (PWID) and are interested in improving their HIV prevention and substance use treatment. Participants should be willing to engage with the LINKED social network intervention or a control group activity, with follow-ups at 6 and 12 months.Inclusion Criteria
Exclusion Criteria
Timeline for a Trial Participant
Screening
Participants are screened for eligibility to participate in the trial
Intervention
Participants receive the LINKED social network intervention or an equal-attention control intervention
Follow-up
Participants are monitored for PrEP and MOUD uptake and adherence
What Are the Treatments Tested in This Trial?
Interventions
- LINKED
Trial Overview
The study tests the LINKED intervention against an equal-attention control group to see if it helps PWID take up PrEP (a medication to prevent HIV) and MOUD (medications for opioid use disorder). It's a cluster randomized trial, meaning groups of participants are randomly assigned to interventions.
How Is the Trial Designed?
2
Treatment groups
Experimental Treatment
Active Control
Participants randomized to the LINKED arm will receive a peer change agent intervention consisting of a 3-hour workshop divided into four learning and practice modules.
Participants randomized to the equal attention control group will receive a group intervention facilitated by trained study staff.
Find a Clinic Near You
Who Is Running the Clinical Trial?
NYU Langone Health
Lead Sponsor
National Institute on Drug Abuse (NIDA)
Collaborator
Citations
Outcomes of a Peer HIV Prevention Program with Injection ...
Results indicated significant HIV risk reduction among all study participants, associated with significant health advocacy action conducted by PHAs, and a ...
Behavioral HIV risk reduction among people who inject drugs
Behavioral interventions reduce risk behaviors among people who inject drugs, especially when interventions target both drug risk and sexual risk behaviors, and ...
HIV prevention intervention for substance users: a review ...
The interventions reviewed demonstrate promising results for decreasing risky sexual practices for NIDUs and reducing high-risk drug practices for IDUs.
HPTN 094 Study Examines a Novel Way to Take Addiction ...
Primary outcomes were being alive at 26 weeks post-randomization, using MOUD, and ART for HIV prevention or care among people who inject drugs ...
Effectiveness of interventions for changing HIV related risk ...
HIV prevention interventions in Nepal have effectively reduced risky behaviours among female sex workers, men who have sex with men and transgender over the ...
Engagement and Substance Dependence in a Primary ...
Among people with substance dependence and HIV or high-risk for HIV, 64% engaged in an addiction treatment program integrated into primary care.
7.
cureus.com
cureus.com/articles/373702-hiv-prevention-among-people-who-inject-drugs-pwid-a-narrative-reviewHIV Prevention Among People Who Inject Drugs (PWID)
Oral PrEP demonstrated 49% reduction in HIV incidence among PWID in an RCT, with ≥70% efficacy among those with detectable drug levels. Real- ...
Unbiased Results
We believe in providing patients with all the options.
Your Data Stays Your Data
We only share your information with the clinical trials you're trying to access.
Verified Trials Only
All of our trials are run by licensed doctors, researchers, and healthcare companies.